True Light Capital
Singaporetruelightcap.com
Overview
True Light Capital is a Greater China-focused asset manager that invests in high-quality opportunities with a nexus to or major business relationship with Greater China.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Syneron Bio | Mar 2026 | Series B | Co-investor |
| Syneron Bio | Mar 2026 | Series B | Co-investor |
| Chengdu Zeling Biomedical Technology Co. Ltd. | Jan 2026 | Series C | Lead |
| Golden Goose | Dec 2025 | Buyout/LBO | Co-investor |
| OTR Therapeutics | Jun 2025 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
